Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) EBIT Margin (2016 - 2025)

Prestige Consumer Healthcare has reported EBIT Margin over the past 16 years, most recently at 29.1% for Q4 2025.

  • Quarterly results put EBIT Margin at 29.1% for Q4 2025, down 257.0% from a year ago — trailing twelve months through Dec 2025 was 29.21% (down 35.0% YoY), and the annual figure for FY2025 was 29.6%, down 83.0%.
  • EBIT Margin for Q4 2025 was 29.1% at Prestige Consumer Healthcare, roughly flat from 29.06% in the prior quarter.
  • Over the last five years, EBIT Margin for PBH hit a ceiling of 33.93% in Q2 2021 and a floor of 98.3% in Q1 2023.
  • Median EBIT Margin over the past 5 years was 29.77% (2024), compared with a mean of 23.6%.
  • Biggest five-year swings in EBIT Margin: plummeted -12730bps in 2023 and later soared 12795bps in 2024.
  • Prestige Consumer Healthcare's EBIT Margin stood at 30.09% in 2021, then grew by 5bps to 31.64% in 2022, then dropped by -3bps to 30.71% in 2023, then increased by 3bps to 31.68% in 2024, then dropped by -8bps to 29.1% in 2025.
  • The last three reported values for EBIT Margin were 29.1% (Q4 2025), 29.06% (Q3 2025), and 28.76% (Q2 2025) per Business Quant data.